Author:
Thase Michael E.,Danchenko Natalya,Brignone Melanie,Florea Ioana,Diamand Francoise,Jacobsen Paula L.,Vieta Eduard
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology
Reference47 articles.
1. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder;Alvarez;Int. J. Neuropsychopharmacol.,2012
2. Work Group on Major Depressive Disorder;American Psychiatric Association (APA),2010
3. Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey;Ashton;Curr. Ther. Res. Clin. Exp.,2005
4. The safety and tolerability of vortioxetine: analysis of data from randomized placebo-controlled trials and open-label extension studies;Baldwin;J. Psychopharmacol.,2016
5. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD);Baldwin;Eur. Neuropsychopharmacol.,2012
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献